Exome Asset Management is a culturally diverse, innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices. Exome employs sound investment strategies and a philosophy developed by Samuel D. Isaly, who has spent the majority of his 45-year career focused on both developed and emerging markets healthcare.


Biotechnology

Medical Devices

Exome Asset Management

Sam Isaly

Wongmo Kang

Sameh A.

Gary Garofalo

Myana Chouinard

Joseph Narvaez

Alex Forschner

Exome Asset Management

Org chart

Similar companies